Nutrition Labelling Education Program in Socioeconomically Vulnerable Areas (NCT07531849) | Clinical Trial Compass
RecruitingNot Applicable
Nutrition Labelling Education Program in Socioeconomically Vulnerable Areas
France400 participantsStarted 2026-01-01
Plain-language summary
Front-of-pack nutrition labels (FoPLs) have been adopted in many countries to help consumers rapidly assess the nutritional quality of foods and to encourage healthier choices. Among these schemes, interpretive systems such as Nutri-Score appear particularly promising, as their graphic design improves understanding and use compared with more complex or purely numerical formats. In France, where social inequalities in diet-related chronic diseases are pronounced, implementing and effectively using FoPLs is especially challenging in socioeconomically vulnerable areas. Seine-Saint-Denis, a department with a markedly higher prevalence of diabetes and cardiovascular diseases than the national average, offers a relevant setting to test prevention strategies embedded within routine care. The PEANUTS project is a quasi-experimental before-after interventional study conducted in primary care and hospital outpatient settings, with later extension to the social sector. It aims to evaluate the effectiveness of a brief, literacy-sensitive nutrition education program focused on on-pack nutrition information (Nutri-Score, nutrition facts panel, claims and marketing elements) on self-efficacy, food literacy and the nutritional quality of purchase intentions among adults living in vulnerable territories.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Respondents must be aged 18
* No formal income criterion is applied; Participants are considered as low-income (justified by the fact that the study is conducted in an area known to be socioeconomically vulnerable).
Exclusion Criteria:
* Subjects who are homeless
* Subjects who depend exclusively on food aid (Subjects never engaging in grocery shopping)
* Subjects living outside of mainland France
* French language comprehension will be assessed at baseline using functional health literacy questions in the inclusion questionnaire. Insufficient French literacy will not be used as an exclusion criterion at enrolment. Nevertheless, if analyses show that participants who do not speak and read French have outcome scores that are substantially and systematically lower than those of the rest of the sample, these participants may be excluded from planned sensitivity analyses to preserve data quality and comparability.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Self-efficacy in choosing food products in the supermarket
Timeframe: Pre-intervention, immediately post-intervention, and 1-month follow-up